Why is there so much secrecy surrounding pricing contracts with drug manufacturers?
“We allow third parties to audit at the contract level. What we don’t want to do is make public are the individual contracts because we lose that pricing if we did it. It would actually cost our clients more if we couldn’t preserve that level of privacy. The FTC would agree with this. When you disclose at too granular a level, you actually lose pricing advantage for the consumer. You want transparency for trust, but you don’t want to harm the pricing environment that’s actually good for the consumer.” Q. How urgent is it to reform health care? “It is vitally urgent. The mistake we as Americans make is that we wait until we are in dire straits. With health care, if we wait until we can wait no longer, the choice that we have to transition to a more effective will go away. We will be left with one choice, which is a socialized single-payer system.” “I believe the government should promulgate and regulate and the private sector should operate and innovate. The government needs to create a
